Fund Holdings — Rhenman & Partners Asset Management AB

Total Portfolio Value:
$870.00M
Total Bought:
$182.30M
Total Sold:
$290.73M
Net Transaction:
-$108.43M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
UnitedHealth Group Incorporated(UNH)60,53077,430+16,900$30.62M$40.55M4.66%+$9.93M
Eli Lilly and Company(LLY)45,45041,750-3,700$35.09M$34.48M3.96%-$605.7K
Vertex Pharmaceuticals Incorporated(VRTX)50,00066,750+16,750$20.14M$32.36M3.72%+$12.23M
McKesson Corporation(MCK)34,11747,217+13,100$19.44M$31.78M3.65%+$12.33M
Boston Scientific Corporation(BSX)444,000300,000-144,000$39.66M$30.26M3.48%-$9.39M
Glaukos Corporation(GKOS)36,531270,000+233,469$5.48M$26.57M3.05%+$21.10M
Gilead Sciences, Inc.(GILD)255,500233,500-22,000$23.60M$26.16M3.01%+$2.56M
PROCEPT BioRobotics Corporation(PRCT)420,345448,000+27,655$33.85M$26.10M3.00%-$7.75M
Intuitive Surgical, Inc.(ISRG)64,00051,500-12,500$33.41M$25.51M2.93%-$7.90M
Alignment Healthcare, Inc.(ALHC)1,761,1921,337,284-423,908$19.81M$24.90M2.86%+$5.09M
Medtronic plcSHS(MDT)269,500255,000-14,500$21.53M$22.91M2.63%+$1.39M
Molina Healthcare, Inc.(MOH)34,20068,200+34,000$9.95M$22.46M2.58%+$12.51M
Elevance Health, Inc.(ELV)23,15048,950+25,800$8.54M$21.29M2.45%+$12.75M
Regeneron Pharmaceuticals, Inc.(REGN)43,45731,750-11,707$30.96M$20.14M2.31%-$10.82M
The Cooper Companies, Inc.(COO)115,000236,000+121,000$10.57M$19.91M2.29%+$9.33M
Bristol-Myers Squibb Company(BMY)0325,000+325,000$0$19.82M2.28%+$19.82M
Natera, Inc.(NTRA)123,410138,500+15,090$19.54M$19.59M2.25%+$49.5K
Endeavour Silver Corp.(EXK)471,000440,000-31,000$26.47M$19.05M2.19%-$7.42M
BioMarin Pharmaceutical Inc.(BMRN)250,623265,000+14,377$16.47M$18.73M2.15%+$2.26M
AbbVie Inc.(ABBV)124,15088,650-35,500$22.06M$18.57M2.13%-$3.49M
Tenet Healthcare Corporation(THC)197,700126,700-71,000$24.96M$17.04M1.96%-$7.91M
Insulet Corporation(PODD)57,00061,000+4,000$14.88M$16.02M1.84%+$1.14M
CVS Health Corporation(CVS)267,500235,862-31,638$12.01M$15.98M1.84%+$3.97M
Jazz Pharmaceuticals plcSHS USD(JAZZ)145,500124,300-21,200$17.92M$15.43M1.77%-$2.49M
Insmed Incorporated(INSM)61,500185,500+124,000$4.25M$14.15M1.63%+$9.91M
Oscar Health, Inc.CL A(OSCR)1,362,4211,022,743-339,678$18.31M$13.41M1.54%-$4.90M
Alnylam Pharmaceuticals, Inc.(ALNY)17,00048,197+31,197$4.00M$13.01M1.50%+$9.01M
Royalty Pharma plcCL A(RPRX)595,000411,000-184,000$15.18M$12.79M1.47%-$2.38M
Axsome Therapeutics, Inc.(AXSM)122,600109,600-13,000$10.37M$12.78M1.47%+$2.41M
Humana Inc.(HUM)55,23046,830-8,400$14.01M$12.39M1.42%-$1.62M
DexCom, Inc.(DXCM)0155,000+155,000$0$10.58M1.22%+$10.58M
Neurocrine Biosciences, Inc.(NBIX)100,31789,817-10,500$13.69M$9.93M1.14%-$3.76M
Zimmer Biomet Holdings, Inc.(ZBH)124,00087,250-36,750$13.10M$9.87M1.14%-$3.22M
The Cigna Group(CI)78,38528,200-50,185$21.65M$9.28M1.07%-$12.37M
Cencora Inc53,75032,375-21,375$12.08M$9.00M1.03%-$3.07M
Danaher Corporation(DHR)63,95241,952-22,000$14.68M$8.60M0.99%-$6.08M
Centene Corporation(CNC)195,482126,000-69,482$11.84M$7.65M0.88%-$4.19M
Dynavax Technologies Corp839,131565,000-274,131$10.72M$7.33M0.84%-$3.39M
TG Therapeutics, Inc.(TGTX)262,500177,500-85,000$7.90M$7.00M0.80%-$902.4K
Abbott Labs128,00052,000-76,000$14.48M$6.90M0.79%-$7.58M
Biogen Inc.(BIIB)123,70049,500-74,200$18.92M$6.77M0.78%-$12.14M
Align Technology Inc41,90041,500-400$8.74M$6.59M0.76%-$2.14M
Thermo Fisher Scientific Inc.(TMO)15,64012,640-3,000$8.14M$6.29M0.72%-$1.85M
HCA Healthcare, Inc.(HCA)34,37916,778-17,601$10.32M$5.80M0.67%-$4.52M
Syndax Pharmaceuticals, Inc.(SNDX)232,000433,000+201,000$3.07M$5.32M0.61%+$2.25M
Anteris Technologies Global Corp.(AVR)01,290,000+1,290,000$0$4.70M0.54%+$4.70M
Astrana Health, Inc.(ASTH)80,000150,000+70,000$2.52M$4.65M0.53%+$2.13M
Verona Pharma PlcADS070,000+70,000$0$4.44M0.51%+$4.44M
Becton, Dickinson and Company(BDX)47,90019,000-28,900$10.87M$4.35M0.50%-$6.51M
Cytokinetics, Incorporated(CYTK)149,250104,250-45,000$7.02M$4.19M0.48%-$2.83M
IQVIA Holdings Inc.(IQV)29,00022,000-7,000$5.70M$3.88M0.45%-$1.82M
Janux Therapeutics, Inc.(JANX)170,000141,627-28,373$9.10M$3.82M0.44%-$5.28M
Encompass Health Corporation(EHC)56,00037,400-18,600$5.17M$3.79M0.44%-$1.38M
Akero Therapeutics Inc092,500+92,500$0$3.74M0.43%+$3.74M
Nuvalent Inc72,50052,500-20,000$5.68M$3.72M0.43%-$1.95M
Mirum Pharmaceuticals, Inc.(MIRM)73,75573,7550$3.05M$3.32M0.38%+$272.9K
BioNTech SEADS(BNTX)52,75035,750-17,000$6.01M$3.26M0.37%-$2.76M
Krystal Biotech, Inc.(KRYS)23,75017,750-6,000$3.72M$3.20M0.37%-$520.4K
Merus N V74,50074,5000$3.13M$3.14M0.36%+$3.0K
Ultragenyx Pharmaceutical Inc.(RARE)082,000+82,000$0$2.97M0.34%+$2.97M
Nurix Therapeutics, Inc.(NRIX)290,000249,336-40,664$5.46M$2.96M0.34%-$2.50M
Merck & Co., Inc.(MRK)277,50033,000-244,500$27.61M$2.96M0.34%-$24.64M
Arcellx Inc
COMMON STOCK
43,50043,5000$3.34M$2.85M0.33%-$482.4K
Inspire Medical Systems, Inc.(INSP)150,04116,000-134,041$27.81M$2.55M0.29%-$25.27M
Ionis Pharmaceuticals, Inc.(IONS)212,50081,000-131,500$7.43M$2.44M0.28%-$4.99M
Viking Therapeutics, Inc.(VKTX)90,000100,000+10,000$3.62M$2.42M0.28%-$1.21M
Dianthus Therapeutics, Inc.(DNTH)114,000126,627+12,627$2.49M$2.30M0.26%-$188.2K
Privia Health Group, Inc.(PRVA)121,18998,189-23,000$2.37M$2.20M0.25%-$164.9K
Iovance Biotherapeutics, Inc.(IOVA)1,235,448647,827-587,621$9.14M$2.16M0.25%-$6.99M
Xencor, Inc.(XNCR)195,750195,7500$4.50M$2.08M0.24%-$2.42M
Bruker Corporation(BRKR)36,31542,315+6,000$2.13M$1.77M0.20%-$362.6K
MoonLake ImmunotherapeuticsCL A(MLTX)045,000+45,000$0$1.76M0.20%+$1.76M
Esperion Therapeutics Inc Ne1,915,0001,066,495-848,505$4.21M$1.54M0.18%-$2.68M
INmune Bio Inc.(INMB)178,284178,2840$832.6K$1.39M0.16%+$559.8K
Denali Therapeutics Inc.(DNLI)0100,000+100,000$0$1.36M0.16%+$1.36M
Vir Biotechnology, Inc.(VIR)0200,000+200,000$0$1.30M0.15%+$1.30M
Alkermes plcSHS(ALKS)77,99939,000-38,999$2.24M$1.29M0.15%-$955.5K
Kura Oncology, Inc.(KURA)314,526195,000-119,526$2.74M$1.29M0.15%-$1.45M
Arvinas, Inc.(ARVN)155,500183,000+27,500$2.98M$1.28M0.15%-$1.70M
Amgen Inc.(AMGN)3,0004,000+1,000$781.9K$1.25M0.14%+$464.3K
Geron Corporation(GERN)1,000,000783,000-217,000$3.54M$1.24M0.14%-$2.30M
ICON Public Limited CompanySHS(ICLR)07,000+7,000$0$1.22M0.14%+$1.22M
Structure Therapeutics IncADS070,000+70,000$0$1.21M0.14%+$1.21M
Relay Therapeutics, Inc.(RLAY)460,000460,0000$1.90M$1.21M0.14%-$690.0K
Xenon Pharmaceuticals Inc.(XENE)35,00035,0000$1.37M$1.17M0.13%-$197.8K
Medpace Holdings, Inc.(MEDP)6,8003,800-3,000$2.26M$1.16M0.13%-$1.10M
Annexon, Inc.(ANNX)542,500460,000-82,500$2.78M$887.8K0.10%-$1.90M
Immunocore Holdings plcADS(IMCR)58,27828,278-30,000$1.72M$839.0K0.10%-$880.2K
Avantor, Inc.(AVTR)61,82647,826-14,000$1.30M$775.3K0.09%-$527.4K
IDEAYA Biosciences, Inc.(IDYA)82,00039,500-42,500$2.11M$647.0K0.07%-$1.46M
Apellis Pharmaceuticals Inc
COM
195,59128,250-167,341$6.24M$617.8K0.07%-$5.62M
Penumbra, Inc.(PEN)02,200+2,200$0$588.3K0.07%+$588.3K
Repligen Corporation(RGEN)9,0004,500-4,500$1.30M$572.6K0.07%-$722.9K
Immunovant, Inc.(IMVT)145,00025,924-119,076$3.59M$443.0K0.05%-$3.15M
Acadia Healthcare Company, Inc.(ACHC)13,7500-13,750$545.2K$0—-$545.2K
Bio-Techne Corporation(TECH)3,0000-3,000$216.1K$0—-$216.1K
Charles River Laboratories International, Inc.(CRL)14,8500-14,850$2.74M$0—-$2.74M
Igm Biosciences Inc126,0640-126,064$770.3K$0—-$770.3K
Intra-Cellular Therapies Inc176,0000-176,000$14.70M$0—-$14.70M
Novo Nordisk A/SADR(NVO)50,0000-50,000$4.30M$0—-$4.30M
Page 1 of 2
Rhenman & Partners Asset Management AB — 13F Holdings — Q1 2025 | TickerTrail